1
/
of
0
FDA Outsourcing Facilities Reports for H2 2024 – Semaglutide and Tirzepatide
FDA Outsourcing Facilities Reports for H2 2024 – Semaglutide and Tirzepatide
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request: I would like to request full electronic copies of the FDA's outsourcing facilities reports for h2 2024 for semaglutide and tirzepatide
Tags: Pharma, MISC, 2024
Tags: Pharma, MISC, 2024
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. IMPORTANT: The FDA FOIA office operations are currently suspended. We are happy to make the request but do not know when we will receive a response. Learn more about Fast-Track Requests here.
View full details